Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

166.02
Delayed Data
As of 3:59pm ET
 -0.21 / -0.13%
Today’s Change
89.76
Today|||52-Week Range
217.99
+11.16%
Year-to-Date
Intercept Pharmaceuticals Inc (ICPT) CEO & President Mark Pruzanski Sold $5.8 million...
Sep 22 / GuruFocus News - Paid Partner Content
Biotech ETFs in Focus on Tobira Therapeutics' Massive Gain
Sep 21 / Zacks.com - Paid Partner Content
5 Biotech Stocks to Watch as Interest in NASH Increases
Sep 22 / Zacks.com - Paid Partner Content
Allergan Buys NASH Therapy Maker Tobira at Huge Premium
Sep 21 / Zacks.com - Paid Partner Content
Allergan's Boldness may not be Limited to Tobira Deal
Sep 21 / TheStreet.com - Paid Partner Content